Search results

231 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Findings could improve treatment for challenging acute leukemia in children
There is no consensus on the best way to treat mixed phenotype acute leukemia, a rare blood cancer with survival rates of between 47 and 75 percent for children. Researchers from St. Jude Children’s Research Hospital and the University of North Carolina Lineberger Comprehensive Cancer Center have made important discoveries about the genetics of this disease that could lead to better treatment.
Located in News
Researchers clarify role of mutations in glioblastoma
In a preclinical study, researchers led by UNC Lineberger's Ryan Miller, MD, PhD, investigated whether the location of where the mutation occurred within the sequence of the PIK3CA gene affected the mutation’s ability to help drive cancerous growth. They also evaluated whether the location of the mutation would affect the cancer's response to certain treatments.
Located in News
Located in Newsroom / UNC Lineberger in the News
For 7-year-old boy, grandfather’s life is the best birthday gift
Instead of presents, Bryson Mittman asked for donations to support UNC Lineberger's multiple myeloma research program and the Multiple Myeloma Research Foundation.
Located in News
Located in Newsroom / UNC Lineberger in the News
Hursting’s 2016 study among most cited
A study by UNC Lineberger's Stephen Hursting, PhD, MPH, professor of nutrition at the University of North Carolina at Chapel Hill’s Gillings School of Global Public Health, has been recognized as one of the most-cited papers of 2016 in all American Association for Cancer Research journals.
Located in Newsletters / / Honors and Awards / 2018
Located in Newsroom / UNC Lineberger in the News
Smith awarded $8.5M contract to compare treatments for recurrent bladder cancer
UNC Lineberger’s Angela B. Smith, MD, MS, an associate professor in the UNC School of Medicine Department of Urology and director of urologic oncology, and her collaborators were awarded a contract from the Patient-Centered Outcomes Research Institute to compare bladder removal with medical therapy in bladder cancer patients.
Located in News
Stem cells show promise as drug delivery tool for childhood brain cancer
UNC Lineberger’s Shawn Hingtgen, PhD, and his collaborators showed they could shrink tumors in laboratory models of medulloblastoma, and extend life. The study, published in PLOS ONE, is a necessary step toward developing clinical trials that would see if the approach works for children.
Located in News
Anders, Wang selected for American Society of Clinical Oncology Leadership Development Program
UNC Lineberger Comprehensive Cancer Center’s Carey K. Anders, MD, and Andrew Z. Wang, MD, have been selected to participate in the 2018-2019 American Society of Clinical Oncology Leadership Development Program.
Located in Newsletters / / Honors and Awards / 2018